Multiomic analysis of a pleural mesothelioma organoid biobank defines gene dependencies and therapeutic vulnerabilities

Pleural mesothelioma (PM) remains an incurable cancer with few effective therapeutic options and limited understanding of its targetable dependencies, owing in part to a scarcity of clinically relevant, scalable models. Here, we describe establishment of an annotated biobank of 26 patient-derived PM organoids that faithfully recapitulate the clinical, genomic and histopathological landscapes of their parent tumours, including driver mutations, copy-number alterations and mutational signatures. By integrating these organoid models with a complementary collection of low-passage primary PM cell lines, we generate a functional precision oncology platform for PM. Genome-scale CRISPR-Cas9 screening across 23 patient-derived PM models uncovered 1,150 core fitness genes, including 638 not shared with pan-cancer core essentials, highlighting critical requirements for proteostasis, DNA repair, RNA processing and cell-cycle control. Parallel profiling of 106 compounds across 36 PM models revealed broad therapeutic vulnerabilities in proteostasis, growth signalling and epigenetic regulation. Beyond these shared vulnerabilities, both screens uncovered genotype-specific dependencies and drug responses linked to recurrent PM alterations. This functional map of shared and genotype-specific dependencies establishes patient-derived organoids as a scalable platform for precision therapeutic discovery in pleural mesothelioma

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-18
DOI
https://doi.org/10.64898/2026.11.16.766984
Primary Topic
Occupational and environmental lung diseases
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Multiomic analysis of a pleural mesothelioma organoid biobank defines gene dependencies and therapeutic vulnerabilities

Jessica Cantwell, José Antonio Valer, Hayley E. Francies, Sallyanne Meakins et al.
3 links
bioRxiv (Cold Spring Harbor Laboratory)
Occupational and environmental lung diseases
preprint

Multiomic analysis of a pleural mesothelioma organoid biobank defines gene dependencies and therapeutic vulnerabilities

Jessica Cantwell, José Antonio Valer, Hayley E. Francies, Sallyanne Meakins, Marie Shamseddin, Alexandra Beck, Carolin M. Sauer, Joanna Obacz, Carmen Herranz, Giulia Emanuelli, Shriram G. Bhosle, Jose Espejo Valle-Inclán, Niki Veale, Robert Campbell Rintoul, Stefan John Marciniak, Claudia Arnedo-Pac, Mathew J. Garnett, Isidro Cortés‐Ciriano, María Ana García-Casado, S. Brocklesby, Agnieszka E Andres
preprint en

Abstract

Pleural mesothelioma (PM) remains an incurable cancer with few effective therapeutic options and limited understanding of its targetable dependencies, owing in part to a scarcity of clinically relevant, scalable models. Here, we describe establishment of an annotated biobank of 26 patient-derived PM organoids that faithfully recapitulate the clinical, genomic and histopathological landscapes of their parent tumours, including driver mutations, copy-number alterations and mutational signatures. By integrating these organoid models with a complementary collection of low-passage primary PM cell lines, we generate a functional precision oncology platform for PM. Genome-scale CRISPR-Cas9 screening across 23 patient-derived PM models uncovered 1,150 core fitness genes, including 638 not shared with pan-cancer core essentials, highlighting critical requirements for proteostasis, DNA repair, RNA processing and cell-cycle control. Parallel profiling of 106 compounds across 36 PM models revealed broad therapeutic vulnerabilities in proteostasis, growth signalling and epigenetic regulation. Beyond these shared vulnerabilities, both screens uncovered genotype-specific dependencies and drug responses linked to recurrent PM alterations. This functional map of shared and genotype-specific dependencies establishes patient-derived organoids as a scalable platform for precision therapeutic discovery in pleural mesothelioma

bioRxiv (Cold Spring Harbor Laboratory)
European Bioinformatics Institute (GB), Wellcome/MRC Cambridge Stem Cell Institute (GB), University of Cambridge (GB), Royal Papworth Hospital (GB), Cancer Research UK (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Wellcome Sanger Institute (GB), University of Oxford (GB), Cancer Research UK Cambridge Center (GB), Papworth Hospital NHS Foundation Trust (GB), Institute for Medical Research (MY), MRC Toxicology Unit (GB)
Wellcome Trust, June Hancock Mesothelioma Research Fund, Cancer Research UK, National Institute for Health and Care Research, British Lung Foundation, Asthma and Lung UK, NIHR Cambridge Biomedical Research Centre
Good health and well-being
Occupational and environmental lung diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon